Mutagenicity of nitroaromatic compounds

Chemical Research in Toxicology

Volumn 13, Issue 8, 2000, Pages 673-692

  Purohit, V ^a   Basu, A K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROANISOLE; 2 NITROFLUORENE; 3 NITROBENZANTHRONE; 3 NITROFLUORANTHENE; 4 NITROBIPHENYL; 4 NITROQUINOLINE 1 OXIDE; 6 NITROCHRYSENE; ARISTOLOCHIC ACID; AROMATIC NITRO COMPOUND; FURAZOLIDONE; FURYLFURAMIDE; METRONIDAZOLE; MISONIDAZOLE; NITROBENZENE DERIVATIVE; NITROFEN; NITROFURAL; NITROFURAN DERIVATIVE; NITROFURANTOIN; NITROIMIDAZOLE DERIVATIVE; NITROPYRENE; UNCLASSIFIED DRUG;

DNA ADDUCT; DNA BINDING; DNA DRUG COMPLEX; DNA REPAIR; DRUG METABOLISM; DRUG STRUCTURE; ESCHERICHIA COLI; FEMALE; GENE MUTATION; GENOTOXICITY; MAMMAL CELL; MUTAGENICITY; NONHUMAN; RAT; REDUCTION; REVIEW; SALMONELLA TYPHIMURIUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; DNA; DNA DAMAGE; ESCHERICHIA COLI; HYDROCARBONS, AROMATIC; MUTAGENICITY TESTS; MUTAGENS; NITRO COMPOUNDS; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

ESCHERICHIA COLI; MAMMALIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0033841374     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000002x     Document Type: Review

References (222)

1. Carcinogenic action of 4-nitroquinoline-1-oxide
2. Interaction of the water-soluble carcinogen 4-nitroquinoline-N-oxide with DNA
3. In vivo interaction of 4-nitroquinoline-1-oxide, and their derivatives with DNA
4. Reactivity of the diacetyl derivative of the carcinogen 4-hydroxyaminoquinoline-1-oxide with DNA, RNA, and other nucleophiles
5. Seryl-tRNA synthetase and activation of the carcinogen 4-nitroquinoline-1-oxide
6. Atmospheric reaction of polycyclic aromatic hydrocarbons: Facile formation of mutagenic nitro derivatives
7. Detection and characterization of nitro derivatives of some polycyclic aromatic hydrocarbons by fluorescence quenching after thin-layer chromatography: Application to air pollution analysis
8. Nitropyrenes: Isolation, identification, and reduction of mutagenic impurities in carbon black and toners
9. Mutagenicity and genotoxicity of nitroarenes: All nitro containing compounds were not created equal
10. Nitro compounds in environmental mixtures and food
11. Detection of 1-nitropyrene in yakatori (grilled chicken)
12. Environmental carcinogens that may be involved in human breast cancer etiology
13. The genotoxicity, metabolism, and carcinogenicity of nitrated polycyclic hydrocarbons
14. 1-Nitrosopyrene: An intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TA1538
15. Induction of rat mammary gland tumors by 1-nitropyrene, a recently recognized environmental mutagen
16. Tumorigenicty and metabolism of 1-nitropyrene in A/J mice
17. Comparative tumorigenicity of 1-nitropyrene, 1-nitrosopyrene, and 1-aminopyrene administered by gavage to Sprague-Dawley rats
18. Mutagenic activity of surface soil and quantification of 1,3-, 1,6-, and 1,8-dinitropyrene isomers in soil in Japan
19. The presence of mutagen/carcinogen in the excised lung and analysis of lung cancer induction
20. DNA adduct formation in mammalian cell cultures by polycyclic aromatic hydrocarbons (PAH) and nitro-PAH in coke oven emission extract
21. Mutagenic assay of aromatic nitro compounds with Salmonella typhimurium
22. 6-Nitrochrysene is a potent tumorigen in newborn mice
23. Tumorigenicity of nitrated derivatives of pyrene, benz[α]anthracene, chrysene and benzo[α]pyrene in the newborn mouse assay
24. Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice
25. The effects of bay-region methyl substitution on 6-nitrochrysene mutagenicity in Salmonella typhimurium and tumorigenicity in newborn mice
26. Comparative tumorigenicity of nitrochrysene isomers in newborn mice
27. Induction of mammary cancer by 6-nitrochrysene in female CD rats
28. Induction of colon adenocarcinomas in CD rats and lung adenomas in ICR mice by 6-nitrochrysene: Comparison of carcinogenicity and aryl hydrocarbon hydroxylase induction in the target organs of each species
29. Application of capillary gas chromatography to environmental analysis
30. Early formation of DNA adducts compared with tumor formation in a long-term tumor study in rats after administration of 2-nitrofluorene
31. Preneoplastic lesions, DNA adduct formation and mutagenicity of 5-, 7-, and 9-hydroxy-2-nitrofluorene, metabolites of the air pollutant 2-nitrofluorene
32. The structure-function relationships of nitrofluorenes and nitrofluorenones in the Salmonella mutagenicity and CHO sisterchromatid exchange assays
33. 2-Nitrofluorene and related compounds: Prevalence and biological effects
34. 3-Nitrobenzanthrone, a powerful bacterial mutagen and suspected human carcinogen found in diesel exhaust and airborne particulates
35. The contribution of nitrofluoranthenes and nitropyrenes to the mutagenic activity of ambient particulate organic matter collected in southern California
36. The role of nitroarenes in the mutagenicity of airborne particles indoors and outdoors
37. Genetic toxicity and carcinogenicity of mono- and dinitrofluoranthenes
38. Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat
39. Para-Nitrobiphenyl, a new bladder carcinogen in the dog
40. Bladder cancer due to exposure to para-aminobiphenyl: A 17 year follow up
41. Tumors of the urinary bladder in dogs after ingestion of 4-aminodiphenyl
42. Distribution and metabolism of the teratogen nitrofen (2,4-dichloro-4'-nitrodiphenyl ether) in pregnant rats
43. Pancreatic carcinogenesis and naturally occurring pancreatic neoplasms of rats and mice in the NCI carcinogenesis testing program
44. Toxicity and carcinogenicity of nitrofurans
45. DNA adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid
46. On the mutagenicity of nitroimidazoles
47. Atmospheric chemistry of gasphase polycyclic aromatic hydrocarbons: Formation of atmospheric mutagens
48. Metabolism and macromolecular binding of 1-nitronaphthalene in the mouse
49. Dose-related airway-selective epithelial toxicity of 1-nitronaphthalene in rats
50. Aristolochic acid is a direct mutagen in Salmonella typhimurium
51. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium
52. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues
53. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid
54. Biological actions of nitroarenes in short-term test on Salmonella, cultured mammalian cells and cultured human tracheal tissues: Possible basis for regulatory control
55. Mutagenicity and carcinogenicity of nitroarenes and their sources in the environment
56. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons
57. Metabolism of nitro-polycylic aromatic hydrocarbons
58. DNA adducts and carcinogenicity of nitro-polycyclic aromatic hydrocarbons
59. Structural basis of the activity of nitrated polycylic aromatic hydrocarbons
60. Adducts from in vivo action of the carcinogen 4-hydroxyaminoquinoline-1-oxide in rats and from in vitro reaction of 4-acetoxyaminoquinoline-1-oxide with DNA and polynucleotides
61. 6-adenyl arylation of chicken erythrocyte DNA by the ultimate carcinogen of 4-nitroquinoline-1-oxide
62. In vitro DNA modification by the ultimate carcinogen of 4-nitroquinoline-1-oxide: Influence of superhelicity
63. Mutagenicity of N2 guanylarylation is SOS functions dependent and reminiscent of the high mutagenic property of 4NQO
64. Formation of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline 1-oxide
65. Single strand scissions of DNA caused by a carcinogen, 4-hydroxylaminoquinoline 1-oxide
66. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide
67. Construction of mutants of Salmonella typhimurium deficient in 8-hydroxyguanine DNA glycosylase and their sensitivities to oxidative mutagens and nitro compounds
68. Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis
69. Nitroaromatic carcinogens in diesel soot: A review of laboratory findings
70. Metabolism of 1-nitropyrene and formation of DNA adducts in Salmonella typhimurium
71. Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene
72. 2-deoxyguanosinyl DNA adducts upon nitroreduction of the environmental mutagen 1-nitropyrene
73. Identification and mutagenicity of metabolites of 1-nitropyrene formed by rat liver
74. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10 oxide, microsomal metabolites of 1-nitropyrene
75. Structural characterization of the major adducts formed by reaction of 4,5-epoxy-4,5-dihydro-1-nitropyrene with DNA
76. Metabolism and DNA binding of 2-nitropyrene in the rat
77. In vitro and in vivo metabolism of the carcinogen 4-nitropyrene
78. The orientation of the nitro substituent predicts the direct-acting bacterial mutagenicity of nitrated polycyclic aromatic hydrocarbons
79. Comparitive carcinogenicities of 1-, 2-, and 4-nitropyrene and structurally related compounds in the female CD rat
80. Carcinogenicity of nitropyrenes in the newborn female rat
81. Nitroreduction of 4-nitropyrene is primarily responsible for DNA adduct formation in the mammary gland of female CD rats
82. Synthesis, characterization and comparative conformational analysis of N-(deoxyguanosin-8-yl)-aminopyrene addts
83. Reductive metabolism of 1-nitropyrene accompanies deamination of cytosine
84. Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes
85. Synthesis and mutagenicity of 1-nitro-6-nitrosopyrene and 1-nitro-8-nitrosopyrene, potential intermediates in the metabolic activation of 1,6- and 1,8-dinitropyrene
86. Identification of the DNA adduct formed by metabolism of 1,8-dinitropyrene in Salmonella typhimurium
87. DNA binding by 1-nitropyrene and 1,6-dinitropyrene in vitro and in vivo: Effects of nitroreductase induction
88. DNA adduct formation in primary rabbit tracheal epithelial cells following treatment with 1,8-dinitropyrene and its partially reduced derivative, 1-nitro-8-nitrosopyrene
89. Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P450 enzymes in human and rat liver microsomes
90. Aerobic and anaerobic reduction of nitrated pyrenes in vitro
91. Differences in reduction of 1,6-dinitropyrene and 1-nitro-6-nitrosopyrene by rat liver cytosolic enzymes and formation of oxygen reactive metabolites by nitrosoreduction
92. Comparative reduction of 1-nitro-3-nitrosopyrene and 1-nitro-6-nitrosopyrene: Implications for the tumorigenicity of dinitropyrenes
93. Formation of DNA adducts and oxidative DNA damage in rats treated with 1,6-dinitropyrene
94. 2- and C8-modified deoxyguanosine as major products of the in vitro reaction of N-hydroxy-6-aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene
95. 3H]6-nitrochrysene in the preweanling mouse: Identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite
96. Metabolism and DNA binding of the environmental colon carcinogen 6-nitrochrysene in rats
97. Roles of human hepatic and pulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-nitrochrysene
98. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites
99. 3H]2-nitrofluorene to rats in vivo
100. The role of the intestinal microflora in the formation of mutagenic metabolites from the carcinogenic air pollutant 2-nitrofluorene
101. 32P-HPLC
102. Formation and persistence of DNA adducts during and after a long-term administration of 2-nitrofluorene
103. Metabolism of the carcinogenic air pollutant 2-nitrofluorene in the rat
104. An unusual DNA adduct derived from the powerfully mutagenic environmental contaminant 3-nitrobenzanthrone
105. DNA adduct formation from the mutagenic air pollutant 3-nitrobenzanthrone
106. Xanthine oxidasemediated mutagenicity of the bladder carcinogen 4-nitrobiphenyl
107. 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation
108. Mutagenic activity of chlorinated 4-nitrobiphenyl ethers and their nitroso and amino derivatives
109. Mutagenicity of 4-nitrodiphenyl ether and its metabolites
110. Dependence of Salmonella typhimurium enzymes on mutagenicities of nitrobenzene and its derivatives in the presence of rat-liver S9 and norharmon
111. A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: Is it more important than previously expected?
112. Mutagenicity of mononitrobenzene derivatives in the Ames test and rec assay
113. Oxidative DNA damage by a metabolite of carcinogenic and reproductive toxic nitrobenzene in the presence of NADH and Cu(II)
114. Nitrofurazone as a mutagen in Escherichia coli
115. Nitrofurazone: Genotoxicity studies in mammalian cells in vitro and in vivo
116. Mutagenicity of nitrofurantoin and furazolidone in Chinese hamster ovary cell strains
117. Relationships between carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, a food additive
118. The production of carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide
119. 6
120. Metabolic degradation of the nitrofurans
121. The reduction of furacin by cell-free extracts of furacin-resistant and parent-susceptible strains of Escherichia coli
122. Activation of nitrofurazone in animal tissues
123. Breakage of bacterial DNA by nitrofuran derivatives
124. Action of nitrofuran on DNA
125. On the mutagenicity of nitrofurans
126. Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro
127. Bacterial and chemical reduction of nitrofurazone
128. Nitrofuran mutagenicity: Induction of frameshift mutations
129. Mutagenicity of nitrofuran derivatives
130. Genotoxicity and carcinogenicity of metronidazole
131. Metronidazole and antipyrine as probes for the study of foreign compound metabolism
132. Metabolism and pharmacokinetics of metronidazole
133. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes
134. Reaction of reduced metronidazole with guanosine to form an unstable adduct
135. 32P-Postlabeling analysis of the DNA adducts formed by aristolochic acid I and II
136. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: New derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels
137. Involvement of umuDC(st) genes in nitro-pyrene-induced -CG frameshift mutagenesis of the repetitive CG sequence in the hisD3052 allele of Salmonella typhimurium
138. DNA sequence analysis of revertants of the hisD3052 allele of Salmonella typhimurium TA98 using the polymerase chain reaction and direct sequencing: Application to 1-nitropyrene induced revertants
139. Role of human N-acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium NM6001 and NM6002
140. Nitroreduction of nitrated and C-9 oxidized fluorenes in vitro
141. The lacI gene: Its role in lac operon control and its use as a genetic system
142. Carcinogens induce targeted mutations in Escherichia coli
143. Mutagenic specificity in bacteria
144. The mutagenicity and DNA base sequence changes induced by 1-nitroso- and 1-nitropyrene in the cI gene of lambda prophage
145. Mutations induced by aromatic amine DNA adducts in pBR322
146. Mutagenic specificity of reductively activated 1-nitropyrene in Escherichia coli
147. SOS responses and DNA damage tolerance in prokaryotes
148. 3 sequence: Effects of SOS, proofreading, and mismatch repair
149. Mutagenicity of the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in Escherichia coli located in a nonrepetitive CGC sequence
150. The action of 1-nitroso-8-nitropyrene in Escherichia coli: DNA adduct formation and mutational onsequences in the absence of nucleotide excision-repair
151. The influence of local DNA sequence and DNA repair background on the mutational specificity of 1-nitroso-8-nitropyrene in Escherichia coli: Inferences of mutagenic mechanisms
152. The Escherichia coli WP2/WP100 rec assay for detection of potential chemical carcinogens
153. Evaluation of the Escherichia coli K12 inductest for detection of potential chemical carcinogens
154. Use of Rec-bacteria for testing of carcinogenic substances
155. The effect of pretreatment of Escherichia coli CM891 with ethylene-diamine-tetraacetate on sensitivity to a variety of standard mutagens
156. An assessment of the importance of error-prone repair and point mutations to forward mutation to L-azatidine-2-carboxylic acid resisitance in Escherichia coli
157. Action of nitrofurans on E. coli: Mutation and induction and repair of daughter-strand gaps in DNA
158. Nitrofuran induced mutagenesis and error prone repair in Escherichia coli
159. Effects of the umuDC, mucAB, and samAB operons on the mutational specificity of chemical mutagenesis in Escherichia coli: I. Frameshift mutagenesis
160. The mutagenic action of nitroimidazoles. I. Metronidazole, nimoridazole, dimetronidazole and ronidazole
161. Comparison of the genetic activity of 5-nitroimidazole derivatives in Escherichia coli, Neurospora crassa, Saccharomyces cerevisiae, and Drosophila melanogaster
162. Mutagenicity of metronidazole
163. Radiosensitization, mutagenicity and toxicity of Escherichia coli by several nitrofurans and nitroimidazoles
164. The Escherichia coli K-12 SOS chromotest agar spot test for simple, rapid detection of genotoxic agents
165. Application of the SOS chromotest to 10 pharmaceutical agents
166. Effect of excision repair on the mutagenesis of misonidazole
167. An evaluation of the two-fold rule for assessing a positive response in the L5178Y TK ± mouse lymphoma assay
168. An evaluation of the L5178 TK ± mouse lymphoma forward mutation assay using 42 chemicals
169. Mutagenicity of mono-, di- and tri-nitropyrenes in Chinese hamster ovary cells
170. An examination of the weak mutagenic response of 1-nitropyrene in Chinese hamster ovary cells
171. DNA sequence analysis of 1-nitrosopyrene-induced mutations in the hprt gene of Chinese hamster ovary cells
172. The mutagenic potency of 1,8-dinitropyrene in cultured mouse lymphoma cells
173. Mutagenicity, unscheduled DNA synthesis, and metabolism of 1-nitropyrene in the human hepatoma cell line HepG2
174. Pathways for the mutagenesis of 1-nitro-pyrene and dinitropyrenes in the human hepatoma cell cine HepG2
175. Cytotoxic and mutagenic effects of 1-nitropyrene and 1-nitros-opyrene in diploid human fibroblasts
176. Kinds and locations of mutations induced in the hypoxanthineguanine phosphoribosyl transferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase
177. C8 guanine adduct-induced stabilization of a -1 frame shift intermediate in a nonrepetitive DNA sequence
178. Kinds of mutations found when a shuttle vector containing adducts of 1,6-dinitro-pyrene replicates in human cells
179. Analysis of mutations in the K-ras and p53 genes of lung tumors and in the hprt gene of 6-thioguanine-resistant T-lymphocytes from rats treated with 1,6-dinitropyrene
180. Trans-1,2-Dihydro-1,2-dihydroxy-6-aminochrysene is metabolized to form a major adduct with deoxyguanosine and produces mutations in the hprt gene of Chinese hamster ovary cells at G:C basepairs
181. Induction of mutations at the hypoxanthine phosphoribosyl transferase (HPRT) locus in AHH-1 human lyphoblastoid cells
182. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene
183. Chemically-induced sister-chromatid exchange in vivo in bone marrow of Chinese hamsters: An evaluation of 24 compounds
184. Unscheduled DNA synthesis in the liver and mutagenic activity in the urine of rats exposed to 2-nitrofluorene or 2-acetylaminofluorene
185. Correlation between induction of unscheduled DNA synthesis in the liver and excretion of mutagenic metabolites in the urine of rats exposed to 2-nitrofluorene
186. Limited detectability of aromatic amines and derivatives in the V79 mammalian cell mutation test
187. Mutagenic specificity of a derivative of 3-nitrobenzanthrone in the supF shuttle vector plasmids
188. Relationships between molecular structure and chromosomal aberrations in in vitro human lymphocytes induced by substituted nitrobenzenes
189. The action of AF2 on cultured hamster and human cells under aerobic and hypoxic conditions
190. The mutagenicity of nitroaromatic drugs. Effect of metronidazole after incubation in hypoxia in vitro
191. Mutagenic activity of 4 active-principle forms of pharmaceutical drugs
192. Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy
193. Lack of evidence for cancer due to use of metronidazole
194. Cancer after exposure to metronidazole
195. Relationship between polarographic reduction potential and mutagenicity of nitroarenes
196. Nitro group orientation, reduction potential and direct-acting mutagenicity of nitro-polycyclic aromatic hydrocarbons
197. Structure, tumorgenicity, microsomal metabolism, and DNA binding of 7-nitrobenz[a,h]-anthracene
198. Structural requirements for the mutagenicity of environmental nitroarenes
199. The influence of methyl substitution on the mutagenicity of nitronaphthalenes and nitrobiphenyls
200. Disubstituted amino-, nitroso-, and nitrofluorenes: A physicochemical basis for structure-activity relationships in Salmonella typhimurium
201. Quantitative structure-activity relationship investigation of the role of hydrophobicity in regulating mutagencity in the Ames test: 2. Mutagencity of aromatic and heteroaromatic nitro compounds in Salmonella typhimurium TA100
202. An improved bacterial test system for the detection and classification of mutagens and carcinogens
203. Detection of carcinogens as mutagens: Bacterial tester strains with R factor plasmids
204. Repair promoted plasmid pKM101 is different from SOS repair
205. Mutagenicity of metronidazole: Activation by mammalian liver microsomes
206. Activation of nitrofurantoin to a mutagen by rat liver nitroreductase
207. Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in microbial systems
208. A cautionary note on the use of nitroreductase-deficient strains of Salmonella typhimurium for the detection of nitroarenes as mutagens in complex mixtures including diesel exhausts
209. Evidence for the existence of a family of bacterial nitroreductases capable of activating nitrated polycyclics to mutagens
210. 6 to the mutagenic action of nitroarenes
211. 6 catalyzes DNA-binding as the cause of mutagenicity
212. 4-Nitroquinoline-1-oxide: Factors determining its mutageniclty in bacteria
213. Diphenyl ether herbicides and related compounds: Structure-activity relationships as bacterial mutagens
214. Diphenyl Ether Herbicides: Mutagenic metabolites and photoproducts of Nitrofen
215. Nitrated fluorene derivatives are potent frameshift mutagens
216. Relationship between mutagenic potency in Salmonella typhimurium strains and the chemical structure of nitro biphenyls
217. Biodegradation of herbicide chlornitrofen (CNP) and mutagenicity of its degradation products